Page 3 - Katharine Wright News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dayton Opera - Finding Wright: A Dayton Opera Premiere - Feb 25/27 - Schuster Center

Wind farms to generate power and jobs for the Southern Downs Published Wednesday, 21 April, 2021 at 12:06 PM Deputy Premier and Minister for State Development, Infrastructure, Local Government and Planning The Honourable Dr Steven Miles Two windfarms and up to 400 jobs in the Southern Downs are a step closer to reality with the State Assessment and Referral Agency giving the green light. Deputy Premier and Planning Minister Steven Miles said Acciona received approval to build the $1.96 billion MacIntyre Wind Farm Precinct (the Precinct) at Cement Mills, approximately 40 kilometres south-west ...

share: This news release, issued by Johns Hopkins Medicine, describes a novel targeted immunotherapy approach. This new approach employs bispecific antibodies to treat cancer by eliciting a Tcell response against mutated p53. The researchers used the Highly Automated Macromolecular Crystallography (AMX) and Frontier Microfocusing Macromolecular Crystallography (FMX) beamlines to characterize the molecular structure of the proteins. AMX and FMX are beamlines at the National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science User Facility at Broo...

8th March 2021 Feature On International Women’s Day, Key.Aero explores the many women who have broken down barriers in aviation. Read on to find out which famous aviator’s couldn’t have succeeded without the help of their sister…   Beatrice ‘Tilly’ Shilling OBE (8 March 1909 – 18 November 1990)  On what would have been her birthday, there is no better place to start with our count of incredible aviation pioneers for International Women’s Day than with Beatrice Shilling. Educated at Manchester University, Shilling’s discipline was within the aeronautical engi...

Novel immunotherapy approach targets cancers Appeared in BioNews 1086 Designer antibodies can alert the immune system to cancerous proteins, slowing tumour growth in mice – three independent studies demonstrate. Researchers at the John Hopkins University School of Medicine, Maryland, investigated the notorious cancer proteins, p53 and RAS. Mutations in p53 and RAS are common among cancers, however, drug therapies have been largely unsuccessful. Therefore, researchers aimed to develop specific antibodies, like those of our immune system, to target these proteins instead. Antibodies detect pr...